- Location
superficial femoral artery
"-
FDA Indication for Viabahn Endoprosthesis for Revision of AV Access Is Expanded by Gore
Dec 13, 2013W. L. Gore & Associates (Gore) has obtained the US Food and Drug Administration (FDA) approval for its GORE VIABAHN endoprosthesis for the treatment of stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous ...
Tags: Gore, FDA, GORE VIABAHN, endoprosthesis, AV access
-
Gore Has Obtained an Approval From FDA for Its 25cm Gore Viabahn Endoprosthesis
Nov 11, 2013W. L. Gore & Associates (Gore) has obtained an approval from the US Food and Drug Administration (FDA) for its 25cm GORE VIABAHN endoprosthesis with heparin bioactive surface. The 25cm Gore Viabahn endoprosthesis is intended to treat ...
Tags: disease heal, health, cure, fda
-
Because of FDA 's Approval,Medtronic Complete Se Stent Which Using in Lower Extremities
Sep 26, 2013Medtronic, a US-based manufacturer of implantable heart-rhythm devices, has obtained the US Food and Drug Administration (FDA) approval for the Complete SE (self-expanding) vascular stent for use in superficial femoral artery (SFA) and ...
Tags: Medtronic, Lower Extremities
-
Abbott Completed Its Acquisition of Idev Technologies
Aug 26, 2013Abbott has completed its acquisition of Idev Technologies, a privately held firm that manufactures next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists, for $310m. Abbott believes ...
Tags: Abbott, Idev Technologies
-
Medtronic Submitted Its PMA for The IN.PACT Admiral Drug-Eluting Balloon
Aug 19, 2013Medtronic has submitted its first pre-market approval (PMA) module to the U.S. Food and Drug Administration (FDA) for the IN.PACT Admiral drug-eluting balloon designed to treat atherosclerotic lesions in the superficial femoral artery ...
Tags: Medtronic, Admiral Drug-Eluting
-
First US Patient Is Riverside Methodist Treated with Cook's Zilver Ptx Stent
Dec 21, 2012US-based Riverside Methodist Hospital has implanted the first US patient with Cook Medical's Zilver PTX drug-eluting peripheral stent, designed for use in above-the-knee femoropopliteal artery. The stent, which is coated with paclitaxel ...
Tags: Methodist Hospital, Cook's Zilver PTX Stent, Medicak Device
-
Cook Medical Receives The Approval From FDA for Zilver PTX Drug-Eluting Peripheral Stent
Dec 18, 2012Cook Medical has received the regulatory approval from the US Food and Drug Administration (FDA) for its Zilver PTX drug-eluting peripheral stent, designed for treating peripheral arterial disease (PAD) in the superficial femoral artery. ...
Tags: Cook Medical, FDA, peripheral arterial disease, clinical product
-
Cook Medical Has Presented Three-Year Data From Zilver PTX Trial
Dec 18, 2012Cook Medical has presented three-year data from Zilver PTX trial, which demonstrated 70.7% primary patency in the superficial femoral artery at 36 months using Paclitaxel-eluting stents. The controlled, randomized trail compares to ...
Tags: Zilver PTX trial, clinical study, clinical application, Cook Medical
-
Cordis Obtains Approval From FDA to Use S.M.A.R.T. CONTROL Vascular Stent Systems
Dec 17, 2012Cordis has obtained regulatory approval from the US Food and Drug Administration (FDA) to use its S.M.A.R.T. CONTROL Vascular Stent systems in the superficial femoral artery (SFA) and/or the proximal popliteal artery (PPA). The Stent ...
Tags: FDA, Stent systems, proximal popliteal artery, superficial femoral artery
-
Patient Enrollment Is Completed by Terumo in Osprey Trial
Jul 12, 2012Terumo Interventional Systems has completed enrolling patients in its Occlusive/Stenotic Peripheral Artery REvascularization StudY (OSPREY). The MISAGO stent comprises a nitinol stent pre-mounted on the distal portion of a rapid-exchange ...
Tags: OSPREY Trial, Misago Stent system, superficial femoral artery